Exploring clinical characteristics of bipolar depression: Internal structure of the bipolar depression rating scale

Australian and New Zealand Journal of Psychiatry

Volumn 43, Issue 9, 2009, Pages 830-837

  Chang, Jae Seung ^c   Ahn, Yong Min ^a,b   Yu, Han Young ^a   Park, Hye Jean ^a   Lee, Kyu Young ^d   Kim, Se Hyun ^b   Kim, Yong Sik ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Eulji General Hospital   (South Korea)

Author keywords

Bipolar depression; Bipolar depression rating scale; Hierarchical cluster analysis; Multidimensional scaling

Indexed keywords

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DEPRESSION RATING SCALE; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUCED EXTRAPYRAMIDAL SYMPTOMS SCALE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; RATING SCALE; YOUNG MANIA RATING SCALE;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BIPOLAR DISORDER; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 69449101002     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670903107666     Document Type: Article

References (48)

1. Mitchell PB, Wilhelm K, Parker G, Austin MP, Rutgers P, Malhi GS. The clinical features of bipolar depression: A comparison with matchedmajor depressive disorder patients. J Clin Psychiatry 2001; 62:212-216.
2. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM. Diagnostic guidelines for bipolar depression: A probabilistic approach. Bipolar Disord 2008; 10:144-152.
3. Berk M, Malhi GS, Mitchell PB et al. Scale matters: The need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatr Scand Suppl 2004; (422):39-45.
4. Smith DJ, Forty L, Russell E et al. Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome. Acta Psychiatr Scand 2009; 119:325-329.
5. Berk M, Malhi GS, Cahill C et al. The Bipolar Depression Rating Scale (BDRS): Its development, validation and utility. Bipolar Disord 2007; 9:571-579.
6. Kay SR, Fiszbein A, Opler LA. The positive andnegati ve syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276.
7. Levine SZ, Rabinowitz J. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale. J Clin Psychopharmacol 2007; 27:431-436.
8. Vieta E, Herraiz M, Fernandez A et al. Efficacy andsafety of risperidone in the treatment of schizoaffective disorder: Initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). J Clin Psychiatry 2001; 62:623-630.
9. Sachs GS, Gaulin BD, Gutierrez-Esteinou R et al. Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. J Clin Psychiatry 2007; 68:1377-1383.
10. Lancon C, Auquier P, Reine G, Bernard D, Addington D. Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable period. Schizophr Res 2001; 47:135-140.
11. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: A systematic review andmeta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007; 64:442-455.
12. Gao K, Ganocy SJ, Gajwani P, Muzina DJ, Kemp DE, Calabrese JR. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: Focus on somnolence. J Clin Psychiatry 2008; 69:302-309.
13. Wils V, Goluke-Willemse G. Extrapyramidal syndrome due to valproate administration as an adjunct to lithium in an elderly manic patient. Int J Geriatr Psychiatry 1997; 12:272.
14. Ghaemi SN, Hsu DJ, Rosenquist KJ, Pardo TB, Goodwin FK. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:209-213.
15. Kim JH, Lee BC, Park HJ, Ahn YM, Kang UG, Kim YS. Subjective emotional experience and cognitive impairment in drug-induced akathisia. Compr Psychiatry 2002; 43:456-462.
16. Fitzgerald PB, Rolfe TJ, Brewer K et al. Depressive, positive, negative and parkinsonia n symptoms in schizophrenia. Aust N Z J Psychiatry 2002; 36:340-346.
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
18. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389.
19. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the goldstand ard become a leadweight? Am J Psychiatry 2004; 161:2163-2177.
20. Yi JS, Bae SO, Ahn YM et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (KHDRS). J Korean Neuropsychiatr Assoc 2005; 44:456-465.
21. Iannuzzo RW, Jaeger J, Goldberg JF, Kafantaris V, Sublette ME. Development and reliability of the HAM-D/MADRS interview: An integratedd epression symptom rating scale. Psychiatry Res 2006; 145:21-37.
22. Ahn YM, Lee KY, Yi JS et al. A validation study of the Korean-version of the Montgomery-Asberg Depression Rating Scale. J Korean Neuropsychiatr Assoc 2005; 44:466-476.
23. Emsley R, Rabinowitz J, Torreman M. The factor structure for the Positive andNegati ve Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res 2003; 61:47-57.
24. Collins AA, Remington G, Coulter K, Birkett K. Depression in schizophrenia: A comparison of three measures. Schizophr Res 1996; 20:205-209.
25. Yi JS, Ahn YM, Shin HK et al. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc 2001; 40:1090-1105.
26. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435.
27. Lindenmayer JP, Brown E, Baker RW et al. An excitement subscale of the Positive and Negative Syndrome Scale. Schizophr Res 2004; 68:331-337.
28. Carlson GA, Jensen PS, Findling RL et al. Methodological issues andcontro versies in clinical trials with childand adolescent patients with bipolar disorder: Report of a consensus conference. J Child Adolesc Psychopharmacol 2003; 13:13-27.
29. Patel NC, Patrick DM, Youngstrom EA, Strakowski SM, Delbello MP. Response and remission in adolescent mania: Signal detection analyses of the young mania rating scale. J Am Acad Child Adolesc Psychiatry 2007; 46:628-635.
30. Jung HY, Cho HS, Joo YH et al. A validation study of the Korean-version of the Young Mania Rating Scale. J Korean Neuropsychiatr Assoc 2003; 42:264-269.
31. Inada T. Evaluation and diagnosis of drug-induced extrapyramidal symptoms: Commentary on the DIEPSS and guide to its usage. Tokyo: Seiwa Shoten Publishers, 1996.
32. Kim JH, Jung HY, Kang UG et al. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): A practical combined rating scale for drug-induced movement disorders. Mov Disord 2002; 17:1354-1359.
33. Street H, Sheeran P, Orbell S. Exploring the relationship between different psychosocial determinants of depression: A multidimensional scaling analysis. J Affect Disord 2001; 64:53-67.
34. Kemmler G, Holzner B, Kopp M et al. Multidimensional scaling as a tool for analysing quality of life data. Qual Life Res 2002; 11:223-233.
35. Stephane M, Thuras P, Nasrallah H, Georgopoulos AP. The internal structure of the phenomenology of auditory verbal hallucinations. Schizophr Res 2003; 61:185-193.
36. Grimm LG, Yarnold PR. Reading and understanding more multivariate statistics. Washington, DC: American Psychological Association, 2000.
37. Aldenderfer MS, Blashfield RK. Cluster analysis. Newbury Park, CA: Sage Publications, 1984.
38. Everitt B, Landau S, Leese M. Cluster analysis, 4th edn. New York, NY: OxfordUni versity Press, 2001.
39. Kruskal JB, Wish M. Multidimensional Scaling. Newbery Park, CA: Sage Publications, 1978.
40. Borg I, Groenen PJF. Modern multidimensional scaling, 2nd edn. New York, NY: Springer Science + Business Media, 2005.
41. Kruskal JB. Multidimensional scaling by optimizing goodness-of-fit to a nonmetric hypothesis. Psychometrika 1964; 29:28-42.
42. Cuellar AK, Johnson SL, Winters R. Distinctions between bipolar and unipolar depression. Clin Psychol Rev 2005; 25:307-339.
43. Judd LL, Schettler PJ, Akiskal HS et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 2003; 6:127-137.
44. Tohen M, Greenfield SF, Weiss RD, Zarate CA Jr, Vagge LM. The effect of comorbid substance use disorders on the course of bipolar disorder: A review. Harv Rev Psychiatry 1998; 6:133-141.
45. Swann AC, GerardMoeller F, Steinberg JL, Schneider L, Barratt ES, Dougherty DM. Manic symptoms and impulsivity during bipolar depressive episodes. Bipolar Disord 2007; 9:206-212.
46. Picardi A. Rating scales in bipolar disorder. Curr Opin Psychiatry 2008; 22:42-49.
47. Biondi M, Picardi A, Pasquini M, Gaetano P, Pancheri P. Dimensional psychopathology of depression: Detection of an 'activation' dimension in unipolar depressed outpatients. J Affect Disord 2005; 84:133-139.
48. Benazzi F. Challenging the unipolar-bipolar division: Does mixed depression bridge the gap? Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:97-103.